Health ❯ Healthcare ❯ Pharmaceuticals ❯ Cancer Treatment

Small Cell Lung Cancer

FDA Grants Priority Review to Ifinatamab Deruxtecan for Pretreated Small Cell Lung Cancer

Real-Time Oncology Review and Project Orbis will speed and coordinate evaluation of the B7-H3 antibody–drug conjugate.

EU Drug Panel Backs Imdylltra for Relapsed Small Cell Lung Cancer

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC